Scarica l'app Stockscreener
9.92
6.15%
-0.65
Dopo l'orario di chiusura:
9.95
0.03
+0.30%
Precedente Chiudi:
$10.57
Aprire:
$10.635
Volume 24 ore:
1.21M
Relative Volume:
1.05
Capitalizzazione di mercato:
$965.63M
Reddito:
$1.85M
Utile/perdita netta:
$-95.19M
Rapporto P/E:
-4.4669
EPS:
-2.2208
Flusso di cassa netto:
$-86.88M
1 W Prestazione:
+0.71%
1M Prestazione:
+2.90%
6M Prestazione:
+100.40%
1 anno Prestazione:
+185.06%
Intervallo 1D:
$9.79
$10.69
Intervallo di 1 settimana:
$9.40
$11.05
Portata 52W:
$2.85
$11.05
Anteris Technologies Global Corp Stock (AVR) Company Profile
Nome
Anteris Technologies Global Corp
Settore
Industria
Telefono
651-493-0606
Indirizzo
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
9.92 | 1.03B | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
427.30 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
156.30 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
43.01 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.87 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-12 | Ripresa | Cantor Fitzgerald | Overweight |
| 2026-03-11 | Iniziato | Wells Fargo | Overweight |
| 2025-01-08 | Iniziato | Lake Street | Buy |
| 2025-01-07 | Iniziato | Barclays | Overweight |
| 2025-01-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
Mostra tutto
Anteris Technologies Global Corp Borsa (AVR) Ultime notizie
ChartWatch ASX Scans: CSL, Cochlear, Artrya, Anteris Technologies, AMP, Zip Co, Graincorp, Pexa - Market Index
Anteris Technologies files form S-3 to register 5.39M shares via warrants - MSN
Could Anteris Technologies Global Corp (ASX:AVR) Continue Its Momentum After 162% One-Year Rally? - Kalkine
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026 - Kalkine
Anteris adjusts CDI and common stock balances amid ASX–Nasdaq transfers - TipRanks
Anteris Technologies Sees 51,701 Net CDI Decrease in June 2026 as Investors Shift Holdings to Nasdaq Shares - Kalkine Media
Anteris Files Shelf Registration to Support Advanced Heart Valve Portfolio - TipRanks
Anteris Technologies Files Offering of Up to 5.39 Million Shares - Moomoo
Anteris Technologies Reports Lapse of Restricted Stock Units and Options - TipRanks
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anteris Technologies Global Corp (AVR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anteris Technologies Global Corp - TradingKey
Anteris Technologies (AVR) Surges 3.13% as Shares Approach Key Resistance at $10.04Moving Average Crossovers - dars.gov.et
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Losses as Development Pipeline ProgressesPretax Income Report - newsline.com
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp Azioni (AVR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Anteris Technologies Global Corp Azioni (AVR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
1.24%
2.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):